Life ScienceCompany
Aptimmune Biologics Ownership
Who owns Aptimmune Biologics?
Aptimmune Biologics is owned by Kemin Industries. It was acquired on August 7, 2018.
Aptimmune Biologics Business Overview
Where is Aptimmune Biologics headquartered?
Aptimmune Biologics is headquartered in St. Louis, Missouri.
What sector is Aptimmune Biologics in?
Aptimmune Biologics is a life science company.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.